Oncology

Genentech official sheds light on the current cancer drug pipeline.

Findings could lead to effective new cancer treatments.

Findings may lead to safer cancer treatments without side effects harmful to the brain.

Protein may hold key to eradicating cancer cells.

Afatinib treats patients with advanced squamous cell carcinoma of the lung that progressed after chemotherapy.

Long-term aspirin use may lessen colorectal cancer risk.

Link found between race and breast cancer life expectancy.

Dogs show promise in sniffing out melanoma, bladder, lung, breast, and ovarian cancers.

Policy may mitigate inaccurate perceptions of safety and efficacy for biological products.

Nanotechnology may lead to breakthroughs in the treatment of several diseases.

A significant increase in breast cancer development was found among a specific subset of women.

Recent developments in cancer treatment and research.

Beta-blockers found reduce to stress from hormones that fuel disease progression.

Study may help improve early cancer detection.

Study estimates United States is wasting $45 million every month that biosimilar Zarxio is not on the market.

Blocking oxygen sensor may improve colorectal cancer treatment.

Cancer drug may benefit patients with specific genetic mutation.

Researchers evaluate how PTEN protein regulates cell growth and how mutations can lead to cancer.

Cabozantinib is a potential treatment for patients with advanced renal cell carcinoma who received one prior therapy.

Researchers shed light on association between alcohol consumption and cancer.

Doppler system correctly identified 100% of patients with malignant skin cancer.

Cancer drug significantly reduces the risk for clinically relevant non-major bleeding.

Findings could lead to more effective treatments for diseases such as cancer and multiple sclerosis.

New cancer detection technique may reduce the need for costly low-dose CT scans.

Researchers evaluate how cancer cells adapt and survive in a new bone environment.

Ongoing clinical trial testing guadecitabine in Myelodysplastic syndromes and acute myelogenous leukemia.

Epidermal growth factor receptors may offer cancer treatment target.

A look back at recent developments in cancer research.

A regular dose of aspirin may reduce the risk of early cancer development.

Keytruda is currently approved for patients with unresectable or metastatic melanoma.